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Background: Toll-like receptor 9 (TLR9) recognises unmethylated CpG DNA and
activates a signalling cascade, leading to the production of inflammatory cytokines
such as TNF-α, IL-1, IL-6 and IL-12 via the adaptor protein MyD88. However, the
specific sequence and structural requirements of the CpG DNA for the recognition of
and binding to TLR9 are unknown. Moreover, the 3D structures of TLR9 and the
TLR9-ODN complex have not been determined. In this study, we propose a
reliable model of the interaction of the TLR9 ECD with CpG ODN using
bioinformatics tools.
Results: The three-dimensional structures of two TLR9 ECD-CpG ODN complexes
were constructed using a homology modelling and docking strategy. Based on
the models of these complexes, the TLR9 ECD-CpG ODN interaction patterns
were calculated. The results showed that the interface between the human TLR9
and the CpG ODN molecule is geometrically complementary. The computed
molecular interactions indicated that LRR11 is the main region of TLR9 that
binds to CpG ODN and that five positively charged residues within LRR11 are
involved in the binding of the TLR9 ECD to the CpG ODN. Observations in the
close-up view of these interactions indicated that these five positively charged
residues contribute differently to the binding region within the TLR9 ECD-CpG
ODN complex. 337Arg and 338Lys reside in the binding sites of ODN, forming
hydrogen bonds and direct contacts with the CpG ODN, whereas 347Lys,
348Arg, and 353His do not directly contact the CpG ODN. These results are in
agreement with previously reported experimental data.
Conclusion: In this study, we present two structural models for the human and
mouse TLR9 ECD in a complex with CpG ODN. Some features predicted by this
model are consistent with previously reported experimental data. This complex
model may lead to a better understanding of the function of TLR9 and its
interaction with CpG ODN and will improve our understanding of TLR9-ligand
interaction in general.Background
Toll-Like Receptors (TLRs) recognise pathogen-associated molecular patterns
(PAMPs) and are thought to be the key sensors of invading microbes in the innate im-
mune system. Thirteen TLR members (TLR1-13) have been identified that are
expressed on the cell surface (TLR 1, 2, 4, 5, and 6) or within the endosomal compar-
tment (TLR 3, 7, 8, and 9). The surface-expressed TLRs primarily recognise structural© 2013 Zhou et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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cleic acids [1].
The TLRs are type I integral membrane glycoproteins that consist of a pathogen-
binding ectodomain (ECD) and a cytoplasmic signalling domain, joined by a single
transmembrane helix [2]. Pathogen-binding ectodomains of mammalian TLRs com-
prise 19–25 extracellular leucine-rich repeats (LRRs) and a cytoplasmic toll/inter-
leukin (IL)-1R (TIR) domain [3]. LRRs containing 24–29 amino acids are
responsible for ligand recognition and binding, and the TIR domain is responsible
for downstream signalling.
TLR9 is a receptor for sensing bacterial DNA/CpG-containing oligodeoxynucleotides
(CpG ODN) within the endosomal compartment [4]. Internalised CpG DNA within the
endosome initiates TLR9-mediated signalling via the sequential recruitment of MyD88,
IRAK and TRAF6, which in turn activate important downstream transcription factors
such as NF-κB and AP-1. These transcription factors induce the expression of inflam-
matory cytokines such as TNF-α, IL-6, IL-1β and IL-12 [5]. There are 25 LRRs in the
ECD of human TLR9 (hTLR9); however, it is unknown which LRRs recognise and bind
CpG DNA and which specific amino acids within the LRR are the most important for
mediating recognition and binding.
Many studies have explored the mechanism of CpG DNA binding to its receptor. In
2003, LRRs 2, 5, and 8, bearing long insertions at position 10 following the consensus
Asn residue, were thought to be the recognition sites of TLR9 [6]. LRR8 contains a
6-residue insert, similar to a motif identified in a protein that directly binds to
unmethylated CpG dinucleotide sequences; thus, LRR8 was thought to be a site of CpG
DNA recognition by TLR9 [7]. It was recently proposed that cleavage of the ECD
occurs in mouse TLR9 (mTLR9) and that the fragment starting from LRR15 mediates
ligand recognition [8,9].
In 2009, Peter et al. found that LRRs 2, 5, and 8 contribute to CpG DNA-induced ac-
tivation of TLR9 and that deletion of the inserted sequences at position 10 leads to a
loss of receptor binding ability. They also identified a positively charged region of the
N-terminus that was essential for CpG DNA-induced TLR9 activation [10]. Another
finding indicated that two variants of hTLR9, Pro99Leu within LRR2 and Met400Ile
within LRR13, are associated with altered receptor function with regard to NF-κB acti-
vation and cytokine induction [11], suggesting that the N-terminal fragment preceding
LRR14 also binds to CpG ODN.
Although the above reports provide useful information about the recognition
and binding of CpG ODN to TLR9, detailed information about the precise se-
quence and structural requirements of the TLR9 interaction with CpG ODN is
lacking. It remains unclear which LRR on TLR9 is the binding site(s) for the CpG
ODN are which residues within the LRR directly contribute to the binding, pri-
marily because of the lack of structural information on either TLR9 or the TLR9-
ODN complex.
The aim of this study is to define a structural model for the TLR9-CpG ODN com-
plex and to describe the interaction between TLR9 and CpG ODN using computational
methods. Therefore, we can identify and characterise the LRR region within hTLR9 that
binds to CpG ODN with the higher affinity and further determine which specific resi-
dues are critical for ligand binding.
Zhou et al. Theoretical Biology and Medical Modelling 2013, 10:18 Page 3 of 12
http://www.tbiomed.com/content/10/1/18Results
Residues within LRR11 in hTLR9 provide the greatest number of interactions with CpG ODN
The TLR9-ODN complex was modelled in three steps. First, we predicted the structure
of the TLR9 ECD using a homology modelling approach. Second, we built the ODN in
substrate mode. Third, we docked the CpG ODN substrate to the protein model.
The computed hTLR9 ECD model revealed a horseshoe-shaped assembly that
adopted an irregular solenoid structure with some disordered regions. The compatibil-
ity of the hTLR9 ECD structure with the amino acid sequence was assessed by the
Profiles-3D program in Discovery studio 3.0. The Verify Score of this predicted hTLR9
ECD model was 275.1, which is higher than the Verify Expected Low Score (164.1).
This result indicates that the model is of acceptable quality.
The default protein-DNA docking protocol implemented in Hex 6.12 was used for
the docking runs. The final complex model was characterised in terms of the inter-
action features to improve our understanding of the mechanism of hTLR9-CpG ODN
recognition. The interaction pattern showed that the hTLR9 ECD-CpG ODN inter-
action sites were located close to the central region of the hTLR9 ECD (Figure 1). The
interface between the receptor and the CpG ODN molecule was geometrically comple-
mentary. The interface area of the modelled complex was approximately 1790 Å2, with
a buried surface area of 1720±760 Å2, suggesting that the complex had the “standard-
size” interface of a protein and single-stranded DNA complex [12].
Because of the considerable size of CpG ODN, the ligand-binding region of hTLR9
contained many residues. The residues involved in the protein-nucleic acid interface of
the hTLR9 ECD-CpG ODN complex were determined on the basis of the buried sur-
face area. There were about 25 residues that lost their accessible surface in the hTLR9-
CpG ODN complex. These residues constituted a large contact area to bind the CpG
ODN molecule. The interface area contributed by the protein was 840 Å2, which was
46.9% of the total interface area. Among the 25 residues of hTLR9, residues 224Tyr,Figure 1 The structure of the hTLR9-ODN complex obtained by the Protein-DNA docking method.
The structure of hTLR9 ECD is shown in carton; helical residues and beta sheet residues are coloured
yellow, and the loop and unassigned residues are coloured green. LRR11 is coloured magenta. CpG ODN is
shown in rainbow sticks.
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392Met, and 397Arg were important for ligand recognition, and they established more
direct and closer contact with the CpG ODN molecule.
In their review, Rohs et al. proposed a new theory regarding the origin of specific
recognition between proteins and DNA [13]. They hypothesised that hydrogen bonds
and hydrophobic contacts are principally responsible for the recognition specificity.
Hydrogen-bond interactions are likely the main force dictating DNA sequence reading
by proteins [14]. The hydrophobic bases are more exposed in single-stranded DNA
than in dsDNA, leading to more hydrophobic interactions [15,16]. We examined how
these interactions affect the binding of protein and DNA by analysing the distribution
of these interactions throughout the hTLR9 ECD-CpG ODN complex.
There are 7 intermolecular hydrogen bonds and 29 hydrophobic interactions in the
hTLR9 ECD-CpG ODN complex. The hydrogen bonds and hydrophobic interactions in
this complex model are listed in Table 1 and Table 2, respectively. It has been shown
that 90% of the protein-nucleic acid hydrogen bonds have the donor group on the pro-
tein and the acceptor group on the DNA [12]. Similarly, five of the seven hydrogen
bonds in the hTLR9 ECD-CpG ODN complex have the donor group on the protein,
and the other two have the donor group on the ODN.
Some residues within LRR11, such as 335Asn, 337Arg, 338Lys, and 340Asn, formed
more strong interactions with ODN 1826. Thus, LRR11 may be the main region of
hTLR9 that binds to CpG ODN. This result is consistent with the experimental data in
a prior report. We previously demonstrated that LRR11 peptide could bind to CpG
ODN with high affinity, significantly decreasing CpG ODN internalisation andTable 1 Hydrophobic interactions observed in the complex between human TLR9 and
the ODN
Amino acid Atoms Nucleotide Atoms
TYR224 CZ C8 C30
VAL248 CG1 C8 C50
VAL290 CG2 G9 C50
VAL312 CB G6 C2
VAL312 CG1 C8 C50
VAL312 CG2 A7 C2
ASP314 CB G9 C50
ARG337 CD,CZ A4 C2,C5,C6
ARG337 CZ T5 C2
ARG337 CB,CZ G6 C2,C4,C5,C6
LYS338 CD A7 C2
LYS338 CD,CE C8 C2
LYS338 CE G9 C2
ASN340 CG T10 C50
VAL364 CG1 C3 C5
ALA365 CB A4 C6
LYS367 CE T5 C4,C5
MET392 CE C3 C20,C30
ARG397 CZ T11 C50
Table 2 Hydrogen bond interactions observed in the complex between human TLR9 and
the ODN
Donor Acceptor Distance Angle
A:TYR224:HH S:DG9:OP1 2.18 121.3
A:ARG337:HH22 S:DT5:O2 2.48 86.1
A:LYS338:HZ2 S:DC8:O2 2.06 126.2
A:LYS338:HZ2 S:DG9:N3 2.43 107.2
A:LYS367:HZ1 S:DT5:O4 1.67 129.8
S:DC3:H42 A:GLN335:OE1 2.11 130.1
S:DG6:H22 A:ARG311:O 2.21 165.8
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conferred decreased responses to CpG ODN in HEK293T cells. These results suggest
that LRR11 strongly binds to CpG ODN and that LRR11 may be the main region of
hTLR9 that binds to CpG ODN [17].
Five positively charged residues of LRR11 contribute differently to the binding of hTLR9
to CpG ODN
Analysis indicates that the interfaces where protein interacts with DNA are highly
enriched in positive charges and almost devoid of negative charges [14]. The positively
charged lysine and arginine account for 41% of the average interface area, while the
negatively charged aspartic acid and glutamic acid only account for 4% of the interface
area [12]. In the predicted hTLR9 ECD-CpG ODN complex model, LRR11 was the
main region of hTLR9 binding to CpG ODN. Sequence analysis revealed there are five
positively charged residues within LRR11 of hTLR9.
In our previous report [17], mutational studies indicated that a mutation at any one
of the five residues drastically decreased the affinity of LRR11 for ODN, and among the
five single mutations, R337S and K338N led to the most severe losses of LRR11-ODN
binding. These results demonstrated that all five positively charged residues in LRR11
were essential for the high affinity binding of LRR11 with CpG ODN but that 337Arg
and 338 Lys contributed more than the other residues to the binding affinity.
The docked structure provided insight into the role of the five positively charged resi-
dues in the interaction with the ODN. The computed hTLR9 ECD-CpG ODN complex
showed that Arg337 and Lys338 were located on the concave face of the horseshoe and
that they were the binding sites of the ODN. In the closed view of the binding region
within the complex, the hTLR9 ECD anchored the ODN strand with Arg337 and
Lys338; the other three positively charged residues Lys347, Arg348 and His353 were
not directly involved in binding to the ODN (Figure 2) but were located in the insertion
loop that connected the β-face with the convex surface. The molecular interaction de-
tails showed that Arg337 and Lys338 contributed the main hydrogen bonds in the
hTLR9 ECD-CpG ODN complex and formed direct hydrophobic contacts with the
ODN. Although the three other positively charged residues, Lys347, Arg348 and
His353, did not directly interact with the ODN molecule, mutations at these positions
caused rearrangement of the loop structure of LRR11. The effect of this rearrangement
would propagate to the nearby LRRs, distorting the shape of the TLR9 interface surface.
Figure 2 Close-up views of the interactions between hTLR9 and the ODN. TLR9 is depicted in violet;
Arg337, Lys338, Lys347, Arg348 and His353 are highlighted in cyan and are shown as sticks and balls.
Among the five positively charged residues, only Arg337 and Lys338 were in close contact with the CpG
ODN molecule.
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between the protein and DNA molecules, ensuring an optimal intermolecular contact
[14]. The complementary interface between the hTLR9 ECD and the ODN molecule is
essential for their interaction. The shape of the TLR9 interface surface serves as a dis-
criminating factor for ODN recognition; any alteration of TLR9 surface properties
would influence ligand binding.
A similar phenomenon was reported by others for the D299G polymorphism of
TLR4. The D299G SNP is located in the loop region of LRR10, on the convex face of
TLR4. In a recent report, the substitution of more flexible and neutral residues, such as
Asp299 to Gly299, induced a structural change in the loop region of LRR10-12, which
caused the modulation of TLR4 surface properties and affected ligand binding [18].There are more hydrophobic interactions between mouse TLR9 and the CpG ODN than
between human TLR9 and the CpG ODN
Species-specific ligand binding exists for many TLRs. For example, human and murine
TLR2 can be activated by different lipoproteins [19]. Species-specific differences have
been observed in the recognition of LPS between mammalian species [20-23]. Similarly,
TLR9s in different vertebrate species have distinct CpG ODN specificities; human and
mouse TLR9s display distinct response profiles to CpG-ODN (24, 25). CpG-ODN
containing a GTCGTT motif preferentially activate hTLR9, whereas CpG-ODN with a
GACGTT motif more strongly activate mTLR9. Because it contains a GACGTT motif,
CpG-1826 more potently activated mTLR9 than it activated hTLR9 [24,25].
The factors underlying the receptor’s species specificity remain unknown. The cause
of the activation discrepancy between human and mouse TLR9 for CpG ODN −1826 is
still unclear. To this end, comparative homology modelling and docking studies were
employed to construct a mTLR9 ECD-CpG ODN complex model. We compared the
structure of the mTLR9 ECD-CpG ODN complex with that of hTLR9 ECD-CpG ODN
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complexes.
The pattern of mTLR9 interaction with the CpG ODN exhibited both similarities to
and differences with that of hTLR9 (Figure 3). The hydrogen bonds and hydrophobic
interactions in the mTLR9 ECD-CpG ODN complex are listed in Table 3 and Table 4,
respectively.
The predicted mTLR9 ECD-CpG ODN complex had an interface area of about 1945
Å2, which is greater than that of the hTLR9 ECD-CpG ODN complex. The interface
area measures the area of protein and nucleic acid surface that is buried in contacts
between the two macromolecules. The extent of the contact between two macromole-
cules is indicated by the size of interface area. In the mTLR9 ECD-CpG ODN model,
31 amino acid residues of mTLR9 and 13 nucleotide residues of CpG ODN 1826 were
included in the interface. Among the 31 residues of mTLR9, 6 residues formed hydro-
gen bonds to the CpG ODN, while 13 residues established hydrophobic contacts with
the CpG ODN. More accessible interface area increased the probability of an inter-
action between TLR9 and CpG ODN.
Seven intermolecular hydrogen bonds directly linking the TLR9 protein to the
CpG ODN were observed for both complexes, while more hydrophobic contacts
were observed in the mTLR9 ECD-CpG ODN complex (Table 5). Since the diffe-
rence in hydrophobic interactions was great, the increased number of intermolecular
hydrophobic contacts might promote binding stability. These results indicate that
mTLR9 has a tighter binding with CpG ODN 1826 compared to hTLR9; hence, we
hypothesised that the disparity in the number of hydrophobic interactions may be
the primary reason for the marked differences in CpG-ODN 1826-induced activation
of the two TLR9s.
Similarly to hTLR9, residues within LRR11 in mTLR9 provided more direct contacts
to the CpG ODN molecule. In contrast to hTLR9, Arg-335 within LRR11 in mTLR9 in-
creased the hydrophobic interactions between mTLR9 and CpG ODN 1826 (Table 3).
This residue was likely one of the main reasons why mTLR9 was more responsive to
ODN 1826.Figure 3 Proposed mTLR9 ECD-CpG ODN complex. Both the mTLR9 ECD and the CpG ODN are shown
in carton. The N-terminus (NT) and C-terminus (CT) of the mTLR9 ECD are indicated, with LRR11 highlighted
in magenta.
Table 3 Hydrophobic interactions observed in the complex between mouse TLR9 and
the ODN
Amino acid Atoms Nucleotide Atoms
Tyr224 CE1,CZ C13 C30
Val248 CG1 T14 C7
Glu287 CB,CG,CD T14 C4,C5,C7
Ser311 CB T14 C4
Ser311 CB G15 C6
Val312 CG2 C12 C5
Val312 CB,CG1,CG2 C13 C5, C6
Val312 CB,CG1 T14 C4
Thr334 CB,CG2 G18 C40,C10
Thr334 CB,CG2 T19 C50,C40
Arg335 CA,CB,CG,CD A16 C2,C6
Arg335 CB,CG,CD,CZ C17 C2,C4
Arg335 CD,CZ G18 C2
Arg337 CB,CG,CD,CZ G15 C2,C6
Arg337 CZ C17 C40,C50
Lys338 CB,CG C13 C4
Lys338 CG T14 C2
Phe343 CE1 T10 C50
Val364 CG2 G18 C50
His397 CG,CD2,CE1 T10 C7
His397 CE1 G9 C20,C30
Gln399 CD G9 C50
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Although TLR9 is known to be the receptor for CpG-DNA by directly engaging the
ligand, the precise sequence and structural requirements of TLR9 to promote binding
are unknown. Moreover, it is unclear which residues recognise and bind the CpG DNA
ligand and which LRR is the binding site(s) for CpG DNA or is involved in the binding
site(s). There are no crystal structure data for TLR9; in order to investigate how TLR9
interacts with CpG ODN, the 3D structure of the TLR9 ECD was constructed using
homology modelling. Homology modelling, also referred to as comparative modelling,
is currently the most accurate computational method for protein structure prediction.
A limitation of homology modelling is that the quality of the predicted model strongly
depends on the sequence identity between the target and the template.
The predicted hTLR9 ECD-CpG ODN model suggested that hydrogen bond interac-
tions and hydrophobic contacts between hTLR9 and ODN 1826 play key roles in their
recognition and binding. Residues within LRR11 in hTLR9 provided more interactions
with CpG ODN 1826 than other LRRs. This result indicates that LRR11 may be the
main region of hTLR9 binding to the CpG ODN. This conclusion is in agreement with
results from our previously published experimental data [17].
The model not only identified the binding sites for CpG-ODN but also provided a
structural basis for the species-specific ligand binding. In our observations, the mTLR9
ECD-CpG ODN complex had greater interface area compared with the hTLR9 ECD-
Table 4 Hydrogen bond interactions observed in the complex between mouse TLR9 and
the ODN
Donor Acceptor Distance Angle
A:TYR224:HH S:DC13:OP1 2.41 133.1
A:TYR224:HH S:DC13:O5* 1.84 149.3
A:SER311:HG S:DG15:O6 2.11 111.5
A:LYS338:HZ2 S:DT14:O2 2.28 124.7
A:ASN370:HD22 S:DT10:OP1 2.15 130.5
A:LYS392:HZ1 S:C17:O3* 2.48 152.6
S:DG15:H22 A:ARG337:NE 2.44 105.8
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plain why CpG ODN 1826 activates mTLR9 more potently than hTLR9.
In this study, a modelling approach was successfully applied to generate the struc-
tures of hTLR9 and mTLR9 ECDs. The predicted model of the TLR9-ODN complex
provides us with features that are consistent with the experimental data and can be
considered a rough approximation of how TLR9 might interact with its nucleic acid
substrate. The docked TLR9-ODN complex model provides a structural framework
for interpreting experimental data and further understanding the TLR9 signal trans-
duction process. Finally, these results open new avenues for the computer-aided de-
sign of potential inhibitors or antagonists of the CpG DNA–TLR9 signalling
pathway.Conclusion
By applying molecular modelling and protein docking methods, three-dimensional
structures of two TLR9-CpG ODN complexes were built. With these structures, we
obtained useful information about the detailed interaction between TLR9 and the
ODN ligand. These models provide a novel picture of CpG DNA-TLR9 recognition
and binding and elucidate the mechanism underlying the TLR signal transduction
process.Methods
Data sets
Sequences of human TLR9 and mouse TLR9 in FASTA format were retrieved from the
public database UniProt/ExPASy (Swiss Bioinformatics Resource) http://expasy.org/





Interface residues H-bonds Hydrophobic
contactsNaa Nnuc
mTLR9 ODN CpG 1945 31 13 7 53
hTLR9 ODN CpG 1790 25 12 7 29
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immunostimulatory murine sequence) was used in this study.
Molecular modelling
Searches for reference proteins, sequence alignments and homology modelling were
performed in Discovery Studio 2.5 (Accelrys Inc.). A BLAST search of the PDB indi-
cated that the crystal structures of human TLR3, TLR2 and TLR4 ECD were suitable
template models for the TLR9 ECD. Although the full-length sequence identity be-
tween the TLR9 and the templates is relatively low (26–28%), the presence of highly
conserved LRR motifs in the target and templates suggests that the comparative hom-
ology modelling of the TLR9 ECD using the TLR3, TLR2 and TLR4 ECD structure was
appropriate [27]. For better accuracy, the three-dimensional structures of the
ectodomains of TLR9 were created by I-TASSER, which combines the methods of
threading, ab initio modelling, comparative modelling and structural refinement. The
I-TASSER server is an online platform for protein structure and function predictions.
The I-TASSER server employs a fragment-based method. Here, a hierarchical approach
to protein structure modelling is used in which fragments are excised from multiple
template structures and reassembled based on threading alignments [28]. 3D models
are built based on multiple-threading alignments by LOMETS and iterative TASSER
assembly simulations. I-TASSER (as ‘Zhang-Server’) was ranked the No. 1 server for
protein structure prediction in recent CASP7, CASP8 and CASP9 experiments [29,30].
The final templates selected by I-TASSER were the TLR3 crystal structure (PDB code
2a0z), TLR4 crystal structure (PDB code 3fxi), TLR3 crystal structure (PDB code 1ziw),
TLR4 crystal structure (PDB code 2z64), and TLR2 crystal structure (PDB code 2Z7X).
The quality of the predicted structure was evaluated using the Verify Protein (Profiles-
3D) protocol. Profiles-3D Verify checks the validity of a protein structure (e.g., a hom-
ology model) by measuring the compatibility score of each residue in the given 3D envir-
onment. Scores for each residue and the whole protein are reported, and the expected
high and low scores for a protein of the same size are given as a reference point [31].
We employed the Biopolymer tools in Discovery Studio 2.5 to build the ODN model.
Because TLR9 binds only to single-stranded molecules [32] and the immunostimulatory
activity of CpG-DNA depends on its single-stranded (ss) character [33], we modelled
the ODN structure as a single-stranded DNA molecule. The single-stranded ODN mol-
ecule was generated in B-form using standard helix parameters.
Docking
The program Hex version 6.12 [34] was applied to perform a docking search. In Hex’s
docking calculations, the TLR9 ECD was defined as the receptor, and ODN was used
as the ligand. The shape plus electrostatic correlation algorithms were used. Other pa-
rameters used for the docking process were set to the default values.
The parameters that were used for the docking process via HEX docking software
were as follows:
 Correlation type – Shape plus electrostatic correlation
 FFT Mode – 3D fast life
 Grid Dimension – 0.6
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 Ligand Range – 180
 Twist range – 360
 Distance Range – 40
Protein–DNA interaction analysis
The interface area of a complex is derived from its atomic coordinates by computing
its accessible surface area in solvent and subtracting it from the sum of the accessible
surface areas of the isolated components [12]. Accessible surface areas were evaluated
with the program SURVOL [35], which implements the Lee and Richards algorithm
[36]. Group radii were from ref [37], and the radius of the water probe was 1.4 Å.
A hydrophobic contact is defined as a distance between carbon atoms shorter than
4.5 Å [38]. All hydrophobic contacts between nucleic acid residues and protein residues
are listed.
Protein structure illustrations were generated with the PyMOL Molecular Graphics
Software [39].
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